Postoperative bleeding in myocardial revascularization under cardiopulmonary bypass for patients treated with aspirin or dual antiplatelet therapy using reduced goal-directed anticoagulation
European Journal of Cardio-Thoracic Surgery · 2024
DOI: 10.1093/ejcts/ezae436 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2024. Verfasst von Maroua Eid und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardiac Surgery Department, University Hospital of Angers, 4 Rue Larrey, Angers, 49100, France. Hauptthemen laut MEDLINE: Aspirin, Platelet Aggregation Inhibitors, Postoperative Hemorrhage. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES Antiplatelet therapy increases the risk of bleeding and transfusion in patients undergoing extracorporeal circulation. Reduced goal-directed anticoagulation is a personalized approach to reduce the anticoagulation based on a lower targeted activated clotting time. We assessed whether reduced goal-directed anticoagulation using optimized extracorporeal circulation alleviates the risk of severe bleeding in patients treated by dual antiplatelet therapy (DAPT) compared to aspirin alone during coronary artery bypass grafting (CABG). METHODS A total of 2275 patients undergoing CABG from 2002 to 2022 were selected after propensity matching from a retrospective cohort of 3018 patients. Patients treated with a combination of aspirin and prasugrel or ticagrelor or clopidogrel were included in the DAPT group (n = 1111). Patients treated with aspirin alone (ASA) constituted the control group (n = 1164). Optimized extracorporeal circulation was conducted under reduced systemic anticoagulation with a target activated clotting time 250 s. Severe bleeding was assessed using 3 validated scores of bleeding: UDPB, E-CABG, and BARC-4. RESULTS While all scores showed low ranges of severe bleeding (<6%), they were significantly higher after DAPT compared to ASA (P values for UDPB, E-CABG, and BARC-4 at 0.016, 0.006, and 0.063, respectively). Higher maximal activated clotting time was associated with higher rate of transfusion (P < 0.001) and bleeding (P < 0.001) after multivariate adjustment. Mortality was 1.24% in DAPT vs 0.94% in ASA group (P = NS), whereas cardiac death, myocardial infarction, stroke, and transient ischaemic attack were low (<1%) and similar between groups. CONCLUSIONS Despite higher bleeding under DAPT compared to ASA alone, optimized extracorporeal circulation with reduced goal-directed anticoagulation alleviated severe bleeding which remained low in patients undergoing CABG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiac Surgery Department, University Hospital of Angers, 4 Rue Larrey, Angers, 49100, France.
- Anaesthesiology and Intensive Care Department, University Hospital of Angers, 4 Rue Larrey, Angers, 49100, France.
- Methodology and Biostatistics Department to Clinical Research and Innovation, University Hospital of Angers, 4 Rue Larrey, Angers, 49100, France.
ORCID-Profile: Maroua Eid, Simon Dang Van, Emmanuel Rineau, Jérémie Riou, Christophe Baufreton
Zitieren
APA
Eid, M., Dang Van, S., Hamon, Y., Rineau, E., Riou, J., & Baufreton, C. (2024). Postoperative bleeding in myocardial revascularization under cardiopulmonary bypass for patients treated with aspirin or dual antiplatelet therapy using reduced goal-directed anticoagulation. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezae436
Vancouver
Eid M, Dang Van S, Hamon Y, Rineau E, Riou J, Baufreton C. Postoperative bleeding in myocardial revascularization under cardiopulmonary bypass for patients treated with aspirin or dual antiplatelet therapy using reduced goal-directed anticoagulation. European Journal of Cardio-Thoracic Surgery. 2024. doi:10.1093/ejcts/ezae436
BibTeX
@article{Eid2024,
author = {Eid, Maroua and Dang Van, Simon and Hamon, Yveline and Rineau, Emmanuel and Riou, Jérémie and Baufreton, Christophe},
title = {Postoperative bleeding in myocardial revascularization under cardiopulmonary bypass for patients treated with aspirin or dual antiplatelet therapy using reduced goal-directed anticoagulation},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2024},
doi = {10.1093/ejcts/ezae436}
}
EUVIMED